A. Singh and P. Singh, “TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS”, J. Drug Delivery Ther., vol. 6, no. 5, pp. 97–102, Sep. 2016, doi: 10.22270/jddt.v6i5.1303.